Document is current

Any future updates will be listed below

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

Crossref DOI link: https://doi.org/10.1186/alzrt278

Published Online: 2014-08-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark